Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 20/20 | 0.66 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.47 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | PTGIR | P43119 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL135309 | 0.91 | PTGDR2 (0.78) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL136873 | 0.90 | PTGDR2 (0.69) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL4116144 | 0.90 | PTGDR2 (0.69) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL12900609 | 0.89 | PTGDR2 (0.67) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL12900608 | 0.86 | PTGDR2 (0.64) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL12900610 | 0.86 | PTGDR2 (0.64) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL136134 | 0.86 | PTGDR2 (0.70) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL135073 | 0.85 | PTGDR2 (0.71) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL137599 | 0.85 | PTGDR2 (0.69) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL137889 | 0.85 | PTGDR2 (0.69) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011017201-A2 | DP2 ANTAGONIST AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2011-02-10 | — | — | WO | disclosed |